More association studies on germline variants of other cell cycle regulatory genes such as CDK4, CDK6, CDC2, cyclin D, cyclin A and cyclin B would improve the ability of personalized evaluation of BC susceptibility and prognosis. This evidence concerns the gene CDK4 and breast cancer.